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Atrial flutter is an arrhythmia whose mechanism has fasci-
nated and puzzled many investigators for several decades 
(1-3). Currently there is agreement that common (type 1) 
atrial flutter is based on a reentrant mechanism in the right 
atrium. The demonstration of an excitable gap and the 
possibility of entrainment by pacing (4) argue in favor of a 
reentrant circuit that is mostly functionally determined but 
uses the unique anatomy and fiber orientation of the right 
atrium. 
Although atrial flutter is a common arrhythmia, it is 
frequently difficult to treat. Organic heart disease is often 
present, making termination and prevention of the arrhyth-
mia important. To study the effect of pharmacologic or 
nonpharmacologic interventions, the ability to initiate the 
arrhythmia reproducibly would therefore be very helpful. 
Watson and Josephson (5) showed that in patients with 
documented atrial flutter, programmed electrical stimulation 
of the heart allows induction of the arrhythmia in approxi-
mately 80% of cases. Fixed rate atrial pacing at rapid rates 
(300 to 400 beats/min) or shortly coupled atrial extrastimuli 
introduced during a fast basic pacing rate are usually re-
quired to initiate the arrhythmia in the clinical electrophys-
iology laboratory. In patients, it has also been observed (5) 
that after pacing, a short period of local atrial fibrillation 
often precedes the onset of atrial flutter. 
The present study. Waldo and his group played an impor-
tant role in advancing our knowledge of atrial flutter by 
systematically studying the arrhythmia in the human and 
animal heart. In this issue of the Journal Shimizu et al. (6) 
report interesting observations in their animal model, ex-
tending our understanding of the initiation of atrial flutter by 
atrial pacing. They observe that pacing-induced atrial flutter 
is frequently preceded by transient atrial fibrillation, suggest-
ing an essential role of atrial fibrillation in initiating the 
reentrant mechanism of atrial flutter by creating local slow 
conduction and unidirectional block. 
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The observation that local atrial fibrillation is important 
for the initiation of atrial flutter is not surprising. To start 
reentry in the atrial wall, nonhomogeneity in conduction 
velocity and refractory period duration followed by unidi-
rectional block are required. These circumstances can best 
be provoked by repetitive atrial activation at the shortest 
possible interval. This will maximally abbreviate the atrial 
refractory period, induce slowing in conduction and increase 
the differences in conduction velocity in the longitudinal and 
transversal fiber direction (7). 
How complete is our understanding of atrial flutter in 
humans? Much of our knowledge about atrial flutter comes 
from studies in animal hearts. These range from the model 
based purely on functional properties of the atrium showing 
no excitable gap (8) to models based on a combination of 
functional and anatomic barriers (3,6,9,10) with or without 
an excitable gap. As clinicians, we need to ask how relevant 
these observations in animal models are to our understand-
ing and management of atrial flutter in humans. For example, 
Spinelli and Hoffman (11) recently showed in their animal 
model rapid termination of atrial flutter by the intravenous 
administration of class lA, class IC or class III antiarrhyth-
mic drugs. However, the arrhythmia is rarely terminated 
when these drugs are given intravenously during atrial flutter 
in humans (12). 
Also, in patients with the common (type I) atrial flutter, 
the electrocardiogram shows an atrial deflection having a 
very characteristic configuration, rate and regularity, sug-
gesting a similar atrial activation pattern in those patients. 
This is at variance with the current observations by Shimizu 
et al. (6), who report that in their animal model the direction 
of the reentrant movement in the right atrium depended on 
the site of unidirectional block in the atrium. They found 
three distinct areas of slow conduction and unidirectional 
block in their model. Mapping studies in the human heart 
(13,14) suggest that the area of atrial slow conduction during 
common atrial flutter is located in the low posteroseptal part 
of the right atrium. Saoudi et al. (14) showed that a lesion in 
this area produced by an electrical shock prevented clinical 
recurrence of atrial flutter in five of eight patients. Surgical 
interruption of conduction in the low posteroseptal area of 
the right atrium can also abolish the arrhythmia (15). The 
duration of the follow-up period in patients with atrial flutter 
treated surgically or by electrical ablation is still relatively 
short and we cannot yet exclude the possibility that another 
area in the right atrium might subsequently behave like an 
area with slow conduction and unidirectional block. 
Conclusions. These two examples demonstrate that there 
are differences between the human heart with atrial flutter 
and the animal model. Much progress has been made in our 
understanding of atrial flutter in humans, and the use of 
different animal models of atrial flutter has played an impor-
tant role. Still, some questions remain. We are getting close, 
but do not yet have a final answer. 
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